文献

J-GLOBAL ID：201702251158039437   整理番号：17A1942125

症例対照ワクチン有効性研究:データ収集,解析と結果報告

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results

著者 (30件)： Verani Jennifer R. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Baqui Abdullah H. (International Center for Maternal and Newborn Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, USA) ,  Broome Claire V. (Rollins School of Public Health Emory University, 1518 Clifton Rd, Atlanta, GA, USA) ,  Cherian Thomas (Department of Immunizations, Vaccines and Biologicals, World Health Organization, 20 Avenue Appia, 1211 Geneva, Switzerland) ,  Cohen Cheryl (Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, 1 Modderfontein Rd, Sandringham, Johannesburg, South Africa) ,  Farrar Jennifer L. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Feikin Daniel R. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Feikin Daniel R. (International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, USA) ,  Groome Michelle J. (Respiratory and Meningeal Pathogens Unit, University of Witwatersrand, Richard Ward, 1 Jan Smuts Ave, Braamfontein, Johannesburg, South Africa) ,  Hajjeh Rana A. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Johnson Hope L. (Monitoring & Evaluation, Policy & Performance, GAVI Alliance, Chemin des Mines 2, 1202 Geneva, Switzerland) ,  Madhi Shabir A. (Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, 1 Modderfontein Rd, Sandringham, Johannesburg, South Africa) ,  Madhi Shabir A. (Respiratory and Meningeal Pathogens Unit, University of Witwatersrand, Richard Ward, 1 Jan Smuts Ave, Braamfontein, Johannesburg, South Africa) ,  Mulholland Kim (Murdoch Children’s Research Institute, Royal Children’s Hospital, 50 Flemington Rd, Parkville VIC 3052, Australia) ,  Mulholland Kim (Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK) ,  O’Brien Katherine L. (International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, USA) ,  Parashar Umesh D. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Patel Manish M. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Rodrigues Laura C. (Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK) ,  Santosham Mathuram (International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, USA) ,  Scott J. Anthony (Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK) ,  Scott J. Anthony (KEMRI-Wellcome Trust Research Programme, PO Box 230-80108, Kilifi, Kenya) ,  Smith Peter G. (MRC Tropical Epidemiology Group, London School of Tropical Medicine and Hygiene, London, UK) ,  Sommerfelt Halvor (Centre of Intervention Science in Maternal and Child Health and Centre for International Health, University of Bergen, PO Box 7800, Bergen, Norway) ,  Sommerfelt Halvor (Department of International Public Health, Norwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo, Norway) ,  Tate Jacqueline E. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Victor J. Chris (PATH, 2201 Westlake Avenue, Seattle, WA, USA) ,  Whitney Cynthia G. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA) ,  Zaidi Anita K. (Aga Khan University, Stadium Rd, Karachi, Pakistan) ,  Zell Elizabeth R. (National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, USA)
資料名： Vaccine (Web)  (Vaccine (Web))
巻： 35  号： 25  ページ： 3303-3308  発行年： 2017年 
JST資料番号： U1134A  ISSN： 0264-410X  資料種別： 逐次刊行物 (A)
記事区分： 文献レビュー  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 症例対照法は,認可後のワクチンの有効性を評価するために頻繁に...

シソーラス用語： ヒト ,...
準シソーラス用語： データ提示 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1942125&from=J-GLOBAL&jstjournalNo=U1134A") }}

著者キーワード (3件)： ワクチン ,  症例対照研究 ,  評価研究

分類 (2件)： 感染症・寄生虫症一般  (GD01010H) ,  免疫療法薬・血液製剤の臨床への応用  (GW22020O)

引用文献 (65件)：

• Clemens J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA 1996;275(5):390-7.
• de Andrade ALSS, de-Andrade Jo, Martelli CMT, e Silva SA, de-Oliveira R, Costa MSN, et al. Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil. Int J Epidemiol 2004;33(1):173-81.
• de la Hoz F, Higuera A, Di Fabio J, Luna M, Naranjo A, de la Luz Valencia M, et al. Effectiveness of Haemophilus influenzae type b vaccination against bacterial pneumonia in Colombia. Vaccine 2004;23(1):36-42.
• Adegbola R, Secka O, Lahai G, Lloyd Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet (London, England) 2005;366(9480):144-50.
• Daza P, Banda R, Misoya K, Katsulukuta A, Gessner B, Katsande R, et al. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 2006;24(37-39):6232-9.

タイトルに関連する用語 (7件)： 症例 ,  対照 ,  ワクチン有効性 ,  研究 ,  データ収集 ,  解析 ,  報告